Cerenome, Inc. CNSY
1.99
0.12
6.42%
as of 25 Sep
- Market cap
- $14.3M
- P/E
- 0.0×
Follow CNSY
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (520.84%) | 204.30% | 903.94% | 40,893.33% |
+8 more TTM periods Free account |
|
| (181.53%) | (74.63%) | (195.02%) | (191.33%) | ||
ROIC |
(532.77%) | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(479.69%) | (107.62%) | (719.11%) | (578.27%) | |
Average Days of Receivables |
152.93 | 95.09 | 22.55 | 0.00 | |
Free Cash Flow per Share |
(3.41) | (3.27) | (6.69) | (3.79) | |
Free Cash Flow |
(23.55) | (21.72) | (20.81) | (16.30) | |
Capital Expenditures |
(1.37) | (0.88) | (0.04) | (0.57) | |
Piotroski F-Score |
2.00 | 2.00 | 3.00 | 3.00 | |
| Other line items | |||||
Cash ROIC |
(283.24%) | (75.12%) | (153.84%) | (72.63%) | |
Accounts Receivable Turnover |
3.60 | 7.19 | 10.03 | 0.00 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Inventory Turnover |
0.00 | — | 0.00 | — | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Days of Inventory on Hand |
0.00 | — | 0.00 | — | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
297.57% | 183.10% | 160.73% | 145.00% | |
Selling, General and Administrative Expense of Revenue |
430.55% | 281.26% | 232.73% | 210.92% | |
Share Based Compensation of Revenue |
73.57% | 46.58% | 29.54% | 18.16% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.00 | 1.75 | 0.93 | 0.64 | |
Depreciation/Fixed assets |
0.32 | 0.39 | 1.73 | 2.30 | |
Capex/Depreciation |
(3.02) | (2.23) | (0.08) | (0.91) | |
Revenue per Share |
0.61 | 0.78 | 1.68 | 1.22 | |
Operating CF per Share |
(3.21) | (3.14) | (6.68) | (3.66) | |
Capex per Share |
(0.20) | (0.13) | (0.01) | (0.13) | |
Capex to Sales |
0.33 | 0.17 | 0.01 | 0.11 | |
Net Profit Margin |
(526.48%) | (230.24%) | (429.43%) | (466.64%) |
Columns are period end dates